NGVT News and Press, Ingevity Corporation

Ingevity Corporation (NYSE:NGVT) announced today that it will release its second-quarter 2024 earnings after the stock market close on Wednesday, July 31, 2024. The company will host a live webcast on Thursday, August 1, at 11:00 a.m. (Eastern) to discuss second-quarter 2024 fiscal results. T...

Ingevity Corporation (NYSE:NGVT) today announced the appointment of Ryan C. Fisher as senior vice president, general counsel and secretary and Terry Dyer as senior vice president and chief human resources officer. “We are excited to add Ryan and Terry to our executive leadership team,&...

2024-07-10 10:00:09 ET John McNulty from BMO Capital issued a price target of $45.00 for NGVT on 2024-07-10 08:45:00. The adjusted price target was set to $45.00. At the time of the announcement, NGVT was trading at $40.62. The overall price target consensus is at $59.00...

Ingevity Corporation (NYSE:NGVT) today announced the expansion of its Capa® caprolactone distribution network by establishing Ultrapolymers Group as its distributor for Capa Bioplastics in Europe. Ultrapolymers Group will leverage the company’s experienced sales and technical teams ac...

Ingevity Corporation (NYSE:NGVT) today published its seventh annual Sustainability Report highlighting the advancement of environmental, social and governance sustainability initiatives and commitment to innovating products that assist customers and end users with reducing ecological impact. ...

2024-05-12 21:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-05-04 14:16:08 ET Ingevity Corporation (NGVT) Q1 2024 Earnings Conference Call May 2, 2024 10:00 AM ET Company Participants John Nypaver - Vice President of Investor Relations & Treasurer John Fortson - President & Chief Executive Officer Mary Hall -...

2024-05-01 16:42:29 ET More on Ingevity Ingevity Corporation (NGVT) Q4 2023 Earnings Call Transcript Ingevity Corporation 2023 Q4 - Results - Earnings Call Presentation Ingevity Q1 2024 Earnings Preview Seeking Alpha’s Quant Rating on Ingevity ...

HIGHLIGHT S : (comparisons versus prior year period) Net sales of $340.1 million, down 13% primarily as a result of the repositioning of Performance Chemicals Net loss of $56.0 million and diluted loss per share (EPS) of $1.54; adjusted earnings of $19.1 million and diluted adjust...

Enact Holdings Inc. (ACT) is expected to report $0.99 for Q1 2024 FormFactor Inc. (FORM) is expected to report $0.09 for Q1 2024 SAAB AB - Class B (SAABF) is expected to report for quarter end 2024-03-31 Lumos Pharma Inc. (LUMO) is expected to report $-1.21 for Q1 2024 Axis Capita...